Asterias’ lung cancer vaccine to be trialled by Cancer Research UK
Cancer Research UK is set to conduct a clinical trial for a vaccine considered to be first-of-its-kind for non-small cell lung cancer (NSCLC) based on ‘off-the-shelf’ human stem cells with US firm Asterias Biotherapeutics. CRUK says that if the new vaccine proves to work in clinical trials it could be an option for patients who